Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sotio
Biotech
Sotio taps Biocytogen to create bispecific ADCs in $326M deal
Sotio agreed to pay Biocytogen up to $325.5 million in upfront and milestone fees for rights to bispecific ADC targeting molecules.
Nick Paul Taylor
Jul 16, 2024 9:05am
After halting lead asset, Sotio signs $740M deal with Synaffix
Oct 16, 2023 3:00am
Little European biotech Sotio nabs a super $316M funding round
Dec 3, 2021 7:55am
Unum's CAR-T tech lands at Czech biotech Sotio in $8.1M deal
Aug 31, 2020 8:30am
